For me, it is all about RRR - Risk to Reward Ratio. The only two things that might, and I do mean maybe, could be, a possible reason to not buy into one of the best advancements in medical treatment for a multitude of ailments is the share structure (for some, real scary) and that recently resolved SEC thingie. Basic arithmetic, a modicum of connecting the dots with a dash of clear-headed thinking should set your mind at ease.

My personal favorite (amongst many) is the B Braun same day hip and knee replacement therapy. Then there's MundiPharma, Allay, ... you get the idea, I hope.

For a modest amount of money, you can own beaucoup shares in a medical device and technology that is beyond wonderful. It will change the way we deal with pain. Ponder the implications

The company has been unnervingly quiet of late. So, what to do? Either they are shutting down the operation, going under (not likely) or something big is on the horizon. I'm betting on the latter.

Risk to Reward Ratio - make it your mantra - ignore the noise

take care - WBeacham